AI-generated summary
The authors reviewed published studies on striae distensae (stretch marks), searching PubMed, Web of Science and Scopus for work from 2010 to 2025. They report that several treatments, including 1565 nm non-ablative fractional laser, showed favorable results, with better outcomes in combination therapies. The review notes that some aspects still need clarification and calls for larger studies with standardized assessment methods.
- Who or what was studied
- People with striae distensae (stretch marks)
- Wavelengths
- 1565, 1540, 532 nm
- Limits stated in the abstract
- The abstract calls for larger studies and standardized assessment methods, and states that certain aspects of management require clarification.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Striae distensae (SD) is a common cutaneous condition with an estimated incidence of 56%, associated with rapid skin expansion, hormonal changes, and genetic factors. While traditional treatments (e.g., topical tretinoin, various lasers) exhibit limitations, non-ablative fractional laser (NAFL), injectable fillers, alpha hydroxy acids (AHAs), and combination therapies have emerged as promising modalities, though certain aspects require clarification.
Aims
This review aims to synthesize current evidence on the pathogenesis and management of SD, with a particular focus on evaluating the recent progress of 1565 nm NAFL to provide guidance for clinical practice and future research.
Methods
A systematic literature search was conducted across PubMed, Web of Science, and Scopus databases following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The review prioritized randomized controlled trials, meta-analyses, and substantial clinical studies published between 2010 and 2025.
Results
Striae distensae (SD) arises from mechanical tension, hormonal imbalance, and inflammation-induced dermal matrix disruption. Efficacious treatments include alpha hydroxy acids, injectable fillers, 1540 nm Er:Glass laser, 532 nm Nd:YAG laser, picosecond lasers, intense pulsed light, and combination therapies (e.g., fractional microneedling/CO2 laser + PRP). 1565 nm NAFL exhibits favorable efficacy, safety, and tolerance, with enhanced outcomes in combinations.
Conclusions
The management of SD is evolving towards individualized combination strategies. Fractional microneedling plus PRP and fractional CO2 laser resurfacing with PRP achieve good results in SD rubra and alba, while 1565 nm NAFL represents a significant advance in minimally invasive treatment. Future research should prioritize large-scale studies, standardized assessment methods, and exploration of novel combinations.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1565 nm, 1540 nm, 532 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.